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Caloric restriction (CR) ameliorates cardiac dysfunction associated with obesity. However,
most of the studies have been performed under severe CR (30–65% caloric intake
decrease) for several months or even years in aged animals. Here, we investigated
whether mild (20% food intake reduction) and short-term (2-weeks) CR prevented the
obese cardiomyopathy phenotype and improved the metabolic profile of young (14
weeks of age) genetically obese Zucker fa/fa rats. Heart weight (HW) and HW/tibia length
ratio was significantly lower in fa/fa rats after 2 weeks of CR than in counterparts fed ad
libitum. Invasive pressure measurements showed that systolic blood pressure, maximal
rate of positive left ventricle (LV) pressure, LV systolic pressure and LV end-diastolic
pressure were all significantly higher in obese fa/fa rats than in lean counterparts,
which were prevented by CR. Magnetic resonance imaging revealed that the increase
in LV end-systolic volume, stroke volume and LV wall thickness observed in fa/fa
rats was significantly lower in animals on CR diet. Histological analysis also revealed
that CR blocked the significant increase in cardiomyocyte diameter in obese fa/fa
rats. High resolution magic angle spinning magnetic resonance spectroscopy analysis
of the LV revealed a global decrease in metabolites such as taurine, creatine and
phosphocreatine, glutamate, glutamine and glutathione, in obese fa/fa rats, whereas
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lactate concentration was increased. By contrast, fatty acid concentrations in LV tissue
were significantly elevated in obese fa/fa rats. CR failed to restore the LV metabolomic
profile of obese fa/fa rats. In conclusion, mild and short-term CR prevented an obesity-
induced cardiomyopathy phenotype in young obese fa/fa rats independently of the
cardiac metabolic profile.
Keywords: caloric restriction, hypertrophy, hypertension, nuclear magnetic resonance, metabolite profile,
obesity-induced cardiomyopathy
INTRODUCTION
Obesity is a strong independent risk factor for cardiovascular
(CV) disease and is associated with an increased CV mortality
(Adams et al., 2006; Adabag et al., 2015). The prevalence of
obesity in childhood and adolescence is reaching epidemic
proportions. Moreover, it has been recently shown that increased
body mass index in late adolescence, even within a clinically
accepted normal range, is strongly associated with higher CV
mortality in young adulthood or midlife (Twig et al., 2016).
Unless this clinical situation is addressed at an early stage in life,
it is likely that adverse CV outcomes will occur as a consequence
of cardiac damage resulting from overweight and obesity.
Despite the well-established link between obesity and CV
risk, the pathogenesis of obesity-induced cardiomyopathy is not
fully understood. Several factors as deleterious metabolic and
structural remodeling contribute significantly to the subsequent
functional cardiac damage. In this sense, in the obese-induced
cardiomyopathy the heart undergoes a metabolic remodeling in
response to the high energy demand characterized by a reduction
of the energy reserve compounds as phosphocreatine and by
a lipid overload, both conditions impairing cardiac efficiency
(Kolwicz et al., 2013). Thesemetabolic changes observed in hearts
with obese-induce cardiomyopathy occur early and often precede
later functional changes as ventricular dysfunction (Peterson
et al., 2004). Thus, the most common structural and physiological
changes of the heart in obesity include cardiac hypertrophy and
diastolic dysfunction (Alpert, 2001; Rider et al., 2014), and both
are associated with all-cause mortality (Levy et al., 1988; Bhatia
et al., 2006).
Several strategies are available to protect the heart from
obesity-induced cardiomyopathy, with caloric restriction (CR)
as one of the most common, cost-effective non-pharmacological
and non-surgical interventions used to reduce body weight
(BW) and CV risk. CR is defined as a state in which
energy intake is reduced below normal ad libitum (AL) intake
without malnutrition (García-Prieto and Fernández-Alfonso,
2016). CR increases longevity and improves the outcome of
obesity-associated diseases, including CV disease (Fontana et al.,
2010). Clinical and experimental studies have shown that CR
ameliorates cardiac dysfunction associated with obesity, although
the majority of these studies were carried out under one or
more of the following conditions: (1) high to severe CR regimen
(30–65% reduction of food intake; Zheng et al., 2009; Niemann
et al., 2010; Shinmura et al., 2011; Takatsu et al., 2013; Melo
et al., 2016); (2) long-term CR (several months) (Meyer et al.,
2006; Hammer et al., 2008; Zheng et al., 2009; Niemann et al.,
2010; Melo et al., 2016); and (3) adult or elderly individuals
(Meyer et al., 2006; Hammer et al., 2008; Niemann et al., 2010;
Shinmura et al., 2011). The potential benefits of a milder shorter-
term CR regimen on hearts with obese-induced cardiomyopathy
in a younger population are much less known. Testing a mild
CR regimen and in young animals would help to elucidate the
relative contribution that changes in themetabolic, structural and
functional remodeling have on obese cardiomyopathy in at early
stage of development. Thus, the purpose of the present study was
to investigate the impact of mild (20% food intake reduction)
and short-term (2 weeks) CR on the cardiac phenotype in young
genetically obese Zucker rats through the parallel analysis of
cardiac function, cardiomyocyte structure and metabolic profile.
MATERIALS AND METHODS
Animals and Caloric Restriction Protocol
Eight-week old male obese Zucker rats (fa/fa) and non-obese
control (lean) were housed under specific controlled dark-light
cycles (12/12h, lights on at 8:00 a.m.) and temperature (22◦C),
with standard chow and water ad libitum (AL). To control
BW and food intake, animals were housed individually and
daily monitored for 4 weeks. Then, animals were randomly
divided into two groups and assigned either to an AL or to
a CR diet (80% of AL) for two additional weeks. A scheme
of the protocol is shown in Figure 1A. Adjustment of 20%
CR was done individually based on the previous food intake
values. Rats were weighed before sacrifice. All animal procedures
were conducted in accordance with the recommendations of
the Spanish Animal Care and Use Committee according to
the guidelines for ethical care of experimental animals of the
European Union (2010/63/EU). The study was approved by the
Ethical Committee of Universidad Complutense and Comunidad
de Madrid (reference: PROEX 413/15).
Hemodynamic Parameters
Rats were anesthetized with ketamine (Imalgene 1000, Merial;
80mg/kg i.p.) and xylazine (Rompun 2%, Bayer; 8mg/kg i.p.),
and a 0.58/0.97mm inner- and outer-diameter, respectively,
catheter was inserted in the left ventricle (LV) through the right
carotid artery. The catheter was connected to a data acquisition
system (PowerLab 4/30, ADInstruments, UK) and signals were
digitally stored for analysis using the LabChart 7.0 Pro software.
Systolic (SBP) and diastolic (DBP) blood pressure, LV systolic
pressure (LVSP), LV end-diastolic pressure (LVEDP), the first
derivative of LV pressure rise over time (dP/dtmax), and the
first derivative of LV pressure decline over time (dP/dtmin)
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FIGURE 1 | Scheme of experimental protocol (A) and body weight gain
(B) of lean and fa/fa rats with and without caloric restriction. Half of the animals
of each experimental group were fed with 80% of their daily food intake (CR)
and the other half were maintained on AL diet. Data are mean±SEM (n = 8
animals per group). **P < 0.01 and ***P < 0.001 vs. lean AL group;
+++P < 0.001 vs. lean CR group; ###P < 0.001 vs. fa/fa AL group.
were analyzed. After hemodynamic measurements, animals were
sacrificed and hearts were removed for study. Hearts were
weighed and heart weight (HW)/tibia length ratio was used as
an index of cardiac hypertrophy.
Magnetic Resonance Imaging Acquisition
and Analysis
Magnetic resonance imaging (MRI) was performed with a
Biospec BMT 47/40 spectrometer (Bruker, Ettlingen, Germany)
operating at 4.7-Teslas, equipped with a 12-cm gradient system.
Rats were anesthetized with an isoflurane and oxygen mixture
(3% in oxygen at 1.5 L/min for induction and 1.0–1.5% at 1.0
L/min during experiments). Body temperature was monitored
and maintained at 36◦C. Heart rate (HR) and respiration were
monitored and used to trigger image acquisition with 1025 SAM
monitoring and gating system (SA Instruments, Inc., USA).
Several gradient echo images with different orientations were
acquired to localize the short axis planes. Images were cardiac
and respiratory triggered and up to 7 slices were acquired in a
cardiac cycle. Repetition time (RT) was variable depending on
the animal’s heart and respiration rate. Other imaging parameters
were as follows: echo time (ET) = 2.7 ms; flip angle (θ) = 80◦;
field of view (FOV) = 6 × 6 cm2; slice thickness = 2.0 mm;
matrix size = 128 × 128; number of averaged images = 2. Once
the short axis was set, a multislice white blood CINE sequence
was used to image the rat’s entire heart. For these experiments, a
cardiac and respiratory-triggered FLASH sequence was used. Ten
images per cardiac cycle were acquired to completely cover the
cardiac cycle. Other imaging parameters were as follows: ET = 2
ms; θ = 80◦; FOV = 5.12 × 5.12 cm2; slice thickness = 1.5mm;
matrix size = 128 × 128; number of averaged images = 8. A
total of 8–10 slices were acquired to cover the whole heart. The
data were transferred to a PC for analysis, which was carried
out with ImageJ 1.49v (NIH, USA). For each slice of the CINE
sequence, the LV was segmented in the images corresponding to
diastole and systole. The LV volume for each slice was summed
to obtain the total left ventricular (LV) volume at the end of
diastole and systole (EDV and ESV, respectively). The heart rate
for each rat was calculated as the mean value of the heart rate
during the entire CINE experiment. Ejection fraction (EF), stroke
volume (SV), and cardiac output (CO) were obtained from these
data applying these formula: EF = [EDV-ESV/LVEDV]∗100;
SV= EDV-ESV; CO= SV ∗HR
Histological Analysis
Hearts were fixed in 4% buffered formaldehyde solution
for 48 h. Hearts were sectioned transversally including both
ventricles. Cardiac sections were embedded in paraffin.
Histological sections were obtained at 5µm and stained with
periodic acid solution and Schiff ’s reagent. Cardiomyocytes
of the left ventricular wall were photographed in three high
power fields (×40 objective) for each animal. The minor
diameter of cardiomyocytes was measured. We only measured
those cardiomyocytes with a recognizable nucleus. Diameter
lower than 13µm were rejected since they were considered
as a dichotomy branch of cardiomyocyte; and diameters
higher than 30µm were rejected because borders between
cardiomyocyte were not well delimited. The cardiomyocyte
diameter was obtained using the morphometric ImagenJ
software.
Real-Time PCR for mRNA Collagen Type I
Analysis
Total RNA was extracted from frozen LV tissue with TRIzol
reagent (Invitrogen) and 1µg was reverse transcribed using
the Transcriptor First Strand cDNA Synthesis Kit for RT-PCR
(Roche). Real-time PCR was performed on a MyiQ Real-Time
PCR System (Bio-Rad) using Taqman Gene Expression Assays
(Applied Biosystem). PCR thermocycling parameters were 50◦C
for 2 min, followed by 40 cycles of 95◦C for 15 s and 60◦C for
1 min. Expression of type I collagen was measured using the
Quanti SYBR Green RT protocol (Roche). Melting curve data
were collected to check the PCR specificity. Each cDNA was
amplified in triplicate and the corresponding sample without
reverse transcriptase (no-RT sample) was included as a negative
control. Gene expression levels were normalized to that of 36B4
mRNA. Replicates were then averaged, and fold induction was
determined using a 11Ct-based fold-change calculation. The
primers used were type I collagen (forward primer 5′-AAT GGC
ACG GCT GTG TGC GA-3′, reverse primer 5′- AGC ACT CGC
CCT CCC GTC TT-3′) and 36B4 (forward primer 5′-AGA TGC
AGC AGA TCC GCA T-3′), (reverse primer 5′-GTT CTT GCC
CAT CAG CAC C-3′).
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Metabolites and Fatty Acids Quantified by
1H HR-MAS NMR
High-resolution magic angle spinning (1H HR-MAS) NMR
spectroscopy was performed at 500.13 MHz using a Bruker
AMX500 spectrometer 11.7 T (Bruker Rheinstetten, Germany)
on frozen LV samples placed within a 50µl zirconium oxide
rotor with cylindrical insert and spun at 4000 Hz spinning rate.
Standard solvent suppressed spectra were acquired into 16 k
data points, averaged over 256 acquisitions, total acquisition
∼14 min, using a standard Bruker sequence (noesypr1d) with
a relaxation delay of 2 s and a mixing time of 150 ms. A
spectral with of 8333.33 Hz was used. All spectra were processed
using TOPSPIN software, version 1.3 (Bruker). Prior to Fourier
transformation, the FIDs were multiplied by an exponential
weight function corresponding to a line broadening of 0.3 Hz.
Spectra were phased, baseline-corrected and referenced to the
sodium (3-trimethylsilyl)-2,2,3,3-tetradeuteriopropionate singlet
at δ 0ppm. Several 1H, 1H 2D experiments were performed
to carry out the component assignments. Gradient selected
COSY90 was acquired under the following conditions: water
presaturation during relaxation delay, spectral with of 8333 Hz
in both dimensions, 2 k data points in f2 and 384 increments
in f1. An unshifted sinusoidal window function was applied
in both dimensions and zero filling in f1 dimension.
1H, 1H
TOCSY was registered in TPPI phase-sensitive mode, with water
presaturation during 2 s relaxation delay, a spectral with of 8333
Hz in both dimensions, a 70 ms mixing time, 2 k data points
in f2 and 384 increments in f1. Zero filling in f1 and unshifted
squared sinusoidal window function in both dimensions were
applied before Fourier transformation.
Statistical Analysis
Multivariate statistical algorithms were used to classify 1H HR-
MAS NMR spectra of LV samples and identify distinct metabolic
profiles for the different tissues. For pattern recognition analysis,
1H NMR spectra were data reduced using the software
program AMIX (Analysis of MIXtures version 3.6.8, Bruker)
by subdivision into integral regions of 0.04 ppm between
δ 0.4 and 9 ppm (excluding the water region from 5.2 to
4.7 ppm). Individual integral regions were normalized to the
total sum of integral region following exclusion of the water
resonance. Principal component analysis (PCA) was applied to
the data. Loadings plots from the PCA were used to identify the
peaks mainly responsible for the significant differences. Peaks
were therefore associated with specific metabolites based upon
existing literature. Results were expressed as mean ± SEM. All
comparisons were carried out using Student’s t-test or one-
way analysis of variance with a Neuman-Keuls post hoc test to
compare between groups. Statistical significance was accepted
at P < 0.05. Analysis was performed with GraphPad Prism 5.0
software.
RESULTS
Caloric Restriction and Macroscopic
Parameters
Before CR, both lean AL and fa/fa AL animals gained weight,
but BW increase was significantly higher in fa/fa rats compared
to lean ones at week 12 (Figure 1B), related to cumulative food
intake was also significantly higher in fa/fa AL rats compared to
lean AL ones (Supplemental Figure 1; P < 0.001). During CR,
BW remained stable in fa/fa CR rats, whereas it was significantly
reduced in lean CR animals (P < 0.001). At the end of the
study (14 week-old animals, data summarize in Supplemental
Table 1), BW was significantly higher in fa/fa AL rats compared
to lean AL ones, and significantly decreased in both groups after
CR. However, tibia length (TL) was similar between all groups,
suggesting that CR reduces adipose tissue amount but does not
affect rat growth.
Assessment of Cardiac Function
Invasive pressure measurements showed that SBP was
significantly higher in fa/fa AL than in lean AL rats (152.1
vs. 124.2 mmHg, P < 0.01; Figure 2A), and this increase was
prevented in fa/faCR rats (133.4 mmHg; P< 0.05 compared with
fa/fa AL rats). No differences were found for DBP among groups
(Figure 2B). Both dP/dtmax and dP/dtmin were significantly
higher in fa/fa AL than in lean AL rats (P < 0.05; Figure 2C).
CR normalized the magnitude of dP/dtmax and dP/dtmin in
fa/fa CR rats to the level seen in the lean CR rats, being the
values of both parameters lower in fa/fa CR rats (P = 0.059
and P < 0.05, respectively; Figure 2C). LVSP (Figure 2D) and
LVEDP (Figure 2E) were significantly higher in fa/fa AL than in
lean AL rats (P < 0.01 and P < 0.05, respectively), and both were
normalized in fa/fa CR rats (P < 0.05).
The cardiac MRI images of midventricular slides throughout
cardiac cycle are shown in Figure 3. No differences were found
in heart rate (HR) among groups during MRI analysis (Table 1).
LVEDV but not LVESV, was higher in fa/fa AL than in lean AL
rats (P < 0.05; Table 1), and as a consequence, SV and CO were
also significantly higher in fa/fa AL rats (P < 0.05; Table 1). CR
normalized the magnitude of LVEDV in fa/fa CR rats to the
level seen in the lean CR rats (P < 0.05), and SV significantly
decreased in fa/fa CR rats (P < 0.05). No differences were found
in EF between lean and fa/fa groups of rats independently of food
intake applied (Table 1).
Cardiac Structure and Cardiomyocyte Size
HW (Figure 4A) and HW/tibia length ratio (Figure 4B) were
significantly higher in fa/fa AL than in lean AL rats (P < 0.01).
After CR, HW was significantly lower in both fa/fa CR and
lean CR groups, although HW/tibia length ratio was significantly
lower only in fa/fa CR compared with lean CR rats (P < 0.001;
Figures 4A,B).
LV wall thickness was also greater in fa/fa AL than in lean
AL rats (P < 0.01; Figures 4C,D), and this parameter was
significantly lower in fa/fa CR rats (P < 0.05).
Histological examination of heart tissue (Figure 4E)
illustrated the extent of cardiac hypertrophy in fa/fa AL
rats, which was characterized by an increase in the diameter of
cardiomyocytes in fa/fa AL rats relative to lean AL counterparts
(P < 0.005; Figure 4F). Cardiomyocyte size was lower both in
fa/fa CR and lean CR rats (P < 0.005; Figure 4F). To assess
whether cardiac hypertrophy was associated with myocardial
fibrosis, collagen deposition and collagen I gene levels were
analyzed in lean AL and fa/fa AL rats. There was no evidence of
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FIGURE 2 | Left ventricular pressure characteristics of lean and obese fa/fa rats with and without caloric restriction. (A) Systolic blood pressure (SBP)
and (B) diastolic blood pressure (DBP) in lean and fa/fa rats on AL or CR diet. (C) Maximal rate of pressure increase during systole (dP/dtmax) and maximal rate of
pressure decay during diastole (dP/dtmin) in lean and fa/fa rats on AL and CR diet. (D) Peak left ventricular systolic pressure (LVSP) and (E) Left ventricular
end-diastolic pressure (LVEDP) in lean and fa/fa rats on AL or CR diet. Data are mean±SEM (n = 7–12 animals per group). *P < 0.05, **P < 0.01 vs. lean AL rats;
#P < 0.05 vs. fa/fa AL rats.
pathological fibrosis in Masson’s trichrome-stained sections of
LV (data not shown). Moreover, no differences were detected in
the relative expression of collagen type I mRNA between lean AL
and fa/fa AL rats as measured by quantitative PCR (19.53 ± 0.49
vs. 21.35± 0.92 arbitrary units, respectively, P = 0.117).
Myocardial Metabolites and Fatty Acids
Profile
1H HRMAS NMR spectra showed characteristic signals
from many low molecular weight metabolites, including
taurine, creatine plus phosphocreatine, glutamate, glutamine,
glutathione, alanine and lactate, in LV extracts of each group
(Table 2), as well as fatty acids including n-3 acyl chains,
unsaturated and poly-unsaturated fatty acids (Table 3). 1H
HRMAS NMR analysis of the cardiac metabolites profile
revealed a significant decrease in the concentration of taurine
(P < 0.01), creatine plus phosphocreatine (P < 0.001), glutamate
(P < 0.01), glutamine (P < 0.001), and glutathione (P < 0.01) in
fa/fa AL rats relative to lean AL counterparts. By contrast, lactate
concentration was significantly higher in fa/fa AL rats than
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FIGURE 3 | Cardiac cycle MRI images. Representative transverse mid-papillary MR sections along the cardiac cycle obtained from lean and obese fa/fa rats with
and without short and moderate caloric restriction.
TABLE 1 | Cardiac functional parameters determined by MRI.
Parameters lean AL lean CR fa/fa AL fa/fa CR
HR (bpm) 275.8 ± 15.5 307.7 ± 17.3 284.7 ± 18.4 293.2 ± 15.1
LVEDV (µL) 374.5 ± 36.4 387.9 ± 12.7 494.3 ± 23.8* 399 ± 33.2#
LVESV (µL) 127.3 ± 8.6 116.0 ± 6.3 113.5 ± 3.9 108.4 ± 3.1
EF (%) 68.8 ± 2.7 70.1 ± 1.5 76.9 ± 1.2 72.4 ± 2.0
SV (µL) 256.9 ± 26.0 271.9 ± 11.5 380.8 ± 22.7* 290.7 ± 31.8#
CO (mL/s) 1.25 ± 0.16 1.40 ± 0.12 1.77 ± 0.07* 1.55 ± 0.23
Data are mean± SEM (N= 4–5 for each group). HR, heart rate; LV, left ventricular; LVEDV,
LV end-diastolic volume; LVESD, LV end-systolic volume; EF, ejection fraction; SV, stroke
volume; CO, cardiac output. *P < 0.05 vs. lean AL; #P < 0.05 vs. fa/fa AL.
in lean AL counterparts (P < 0.001; Table 2). With respect to
unsaturated fatty acids, in particular n-3 acyl chains, unsaturated
and poly-unsaturated fatty acids, were all significantly higher
in fa/fa rats than in lean counterparts (P < 0.01 and P < 0.001
Table 3). All these changes observed in both metabolites and
fatty acids cardiac contect in fa/fa AL were unchanged in fa/fa
CR rats. Therefore, mild and short-term CR does not change
the cardiac metabolic profile of genetically obese fa/fa rats. In
fact, the nonsupervised PCA showed a clear clustering of two
groups, one for all lean animals (AL and CR; see dark and light
blue dots into the blue circle of Figure 5), and another for all
fa/fa animals, irrespective of whether that they were on AL or CR
diets (Figure 5; see dark and light red dots into the red circle).
DISCUSSION
The major findings of the present study can be summarized as
follows: (1) short-term (2 weeks) and mild (20%) CR is sufficient
to prevent cardiac dysfunction in young obese fa/fa rats; and (2)
cardiac improvement associated with mild CR occurs even in the
presence of a cardiometabolic profile characteristic of obesity.
Several factors including metabolic, structural and functional
remodeling are involved in the development of obese-induced
cardiomyopathy. Hemodynamic analysis and cardiac MRI were
used to assess in vivo cardiac function. Whereas no changes in
HR were detected between groups, LV cavity, LV wall thickness,
LVEDV, SV and CO were all significantly higher in young
obese fa/fa AL rats than in lean AL counterparts. However, this
occurred despite of unchanged LVESV and EF, indicating that
compensatory hypertrophy occurred in young obese fa/faAL rats
in response to increased overload by higher SBP. Moreover, both
dP/dtmax and dP/dtmin were increased in fa/fa AL rats, which
indicates an enhancement of LV contractility and distensibility
as a compensatory mechanism of cardiac function. Collectively,
these changes in cardiac function are characteristic of early stage
obese cardiomyopathy. Our results are in concordance with the
majority of studies on obese populations in which no effect on
global measures of systolic function, such as LVESV or EF are
observed (Powell et al., 2006; Rider et al., 2014). Prevention
at this early stage is very important in terms of avoiding
advanced obese cardiomyopathy characterized by LV systolic
dysfunction. In the present study, we show that compensatory
cardiac hypertrophy and related functional changes in fa/fa
rats under AL diet can be prevented by CR diet, likely due
to a lower hemodynamic overload normalizing SBP, LVSP and
LVEDP values, and consequently parameters of cardiac function
including LVEDV and SV. Therefore, our results point out that
the prevention of an increase in systolic BP in fa/fa CR rats
was the most probably candidate for avoiding the subsequent
cardiac alterations. In addition to compensatory functional
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FIGURE 4 | Heart dimensions and cardiomyocyte diameter of lean and obese fa/fa rats with and without short and moderate caloric restriction. (A,B)
Heart weight (HW) (A) and HW to tibia length (TL) ratio (HW/TL) (B) of each group of animals. (C) Representative transverse mid-papillary MR sections during end
diastole from lean and obese fa/fa rats with and without short and moderate caloric restriction. (D) Quantitative analysis of LV free wall thickness of each group of
animals. Data are mean±SEM (n = 5 animals per group). *P < 0.05 and **P < 0.01 vs. lean AL rats; #P < 0.05, ###P < 0.001 vs. fa/fa AL rats. (E) Representative
images of cardiomyocyte cross-surfaces obtained from lean and fa/fa rats with and without short and moderate caloric restriction (bar: 100µm). Micrographs of
cardiomyocyte sections were stained with PAS reagent. (F) Quantitative analysis of cardiomyocyte diameter measured inµm of each group of animals. Data are
mean±SEM (n = 5 animals per group). *** P < 0.005 vs. lean AL rats; ###P < 0.005 vs. fa/fa AL rats.
changes in fa/fa rats, structural changes also occurred in the
whole heart and at the level of cardiomyocytes. Thus, HW/tibia
length ratio, LV wall thickness and cardiomyocyte diameter were
all significantly increased in fa/fa AL than in lean AL rats,
and all were prevented by mild short-term CR. Clearly, the
lack of deleterious fibrosis in fa/fa rats probably favored the
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TABLE 2 | Metabolites identified by 1H HRMAS NMR from the Principal Component Analysis (PCA).
lean AL lean CR fa/fa AL fa/fa CR
Taurine (3.42) 44.3 ± 1.42 45.9 ± 2.92 31.84 ± 1.62** 32.45 ± 2.96++
Creatine+Phosphocreatine (3.03) 64.3 ± 1.67 61.7 ± 4.03 42.2 ± 1.28*** 43.1 ± 3.14+++
Glutamate (2.33) 3.6 ± 0.22 3.1 ± 0.18 2.5 ± 0.16** 2.3 ± 0.11+
Glutamine (3.78) 14.8 ± 0.44 13.9 ± 0.51 9.6 ± 0.56*** 10.2 ± 0.79+++
Glutamine/Glutamate 4.2 ± 0.32 4.5 ± 0.30 3.9 ± 0.14 4.4 ± 0.34
Glutathione (4.58) 2.1 ± 0.10 1.9 ± 0.21 1.4 ± 0.07** 1.2 ± 0.05++
Alanine (1.47) 4.5 ± 0.17 4.4 ± 0.25 3.8 ± 0.24 4.0 ± 0.38
Lactate (1.33) 61.5 ± 2.64 66.0 ± 2.54 82.2 ± 4.22*** 86.0 ± 2.94++
Data are mean ± SEM (n = 5 for each group). **P < 0.01, ***P < 0.001 vs. lean AL; +P < 0.05, ++P < 0.01, +++P < 0.001 vs. lean CR. Number between brackets correspond to the
middle point of the bucket.
TABLE 3 | Fatty acids identified by 1H HRMAS NMR from the Principal
Component Analysis (PCA).
lean AL lean CR fa/fa AL fa/fa CR
n-3 acyl chains 36.5 ± 1.68 43.5 ± 4.86 60.7 ± 2.31** 63.2 ± 5.82++
Unsaturated fatty
acids
2.5 ± 0.33 2.7 ± 0.37 5.7 ± 0.38*** 5.2 ± 0.59+++
Poly-unsaturated
fatty acids
1.7 ± 0.05 1.7 ± 0.17 2.3 ± 0.11** 2.1 ± 0.03+
Data are mean ± SEM (n = 5 for each group). **P < 0.01, ***P < 0.001 vs. lean AL;
+P < 0.05, ++P < 0.01, +++P < 0.001 vs. lean CR.
FIGURE 5 | Principal component analysis (PCA) of NMR data. Blue circle
corresponds to lean rats and red circle corresponds to fa/fa rats. Dark blue
dots: lean AL rats; light blue dots: lean CR rats; dark red dots: fa/fa AL rats;
light red dots: fa/fa CR rats.
rapid normalization of hemodynamic parameters and cardiac
function.
With respect to metabolites profile, it has been proposed in
recent years that impairment inmyocardial phosphate energetics,
such as creatine and phosphocreatine depletion, can occur in
cardiac hypertrophy associated with obesity (Rider et al., 2012,
2014). A decline in the total creatine pool together with elevated
fatty acid levels induce an important increase in mitochondrial
uncoupling, which can lead to diastolic dysfunction (Diamant
et al., 2003; Faller et al., 2013). This scenario is evident in
young obese fa/fa rats. We observed a general decrease in the
cardiac concentration of taurine, creatine and phosphocreatine,
glutamate, glutamine, and glutathione linked to the obesity
background of the animals. It has been previously described that
a general drop in the concentration of these metabolites might be
explained by the increase in the extracellular mass due to fibrotic
tissue accumulation and excessive collagen deposition (Roncalli
et al., 2007). However, collagen type I expression was at controls
levels in hearts of fa/fa AL rats and no areas of interstitial fibrosis
were detected. Supporting these results, fa/faAL rats had a similar
glutamine to glutamate ratio to lean AL rats. A decrease in this
ratio would be expected in cardiac fibrosis because transforming
growth factor beta, a key regulator of collagen production,
upregulates phosphate-dependent glutaminase (Roncalli et al.,
2007). Therefore, our results support the notion that hearts
of obese young fa/fa AL rats are no more fibrotic than their
lean AL counterparts, and the alterations in metabolite profile
probably occur only at the level of the cardiomyocyte. The
exception to the general drop in metabolites was for lactate,
whose concentration was significantly higher in fa/fa rats than
in lean rats. This increase in cardiac lactate together with a
significant decrease in glutamate implies a shift to a glycolytic
phenotype in fa/fa rats. Moreover, the accumulation of lactate
derived from pyruvate oxidation has been related to an elevated
energy demand as for example during increased muscle exercise
(Goodwin and Taegtmeyer, 2000), a situation closely associated
with the compensatory cardiac hypertrophy observed in young
obese fa/fa rats. On the other hand, fatty acids are also a
predominant substrate used in the adult myocardium (Kolwicz
et al., 2013). In our study n-3 fatty acyl changes, unsaturated and
poly-unsaturated, significantly accumulated in obese young fa/fa
rats. Therefore, both conditions, i.e. a decrease in the creatine
pool and an accumulation of fatty acids, might be directly
responsible for cardiac dysfunction, especially at the diastolic
level observed in fa/fa rats. Remarkably, we observed that the
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alteration in metabolites and fatty acids were maintained in fa/fa
rats despite normalization of cardiac structure and function by
mild short-term CR. Another possibility to explain these results
might be the fa/fa rats phenotype. This genetic obesity model
develops insulin resistance, which could be also present during
CR, explaining the presence of similar cardiac metabolic profile
observed in fa/fa AL and CR rats. In addition, results from non-
supervised PCA indicated that the main change in the metabolic
profile was not attributable to differences related to cardiac
hypertrophy, hypertension or cardiac diastolic dysfunction, but
rather to obesity background. All these results indicate that the
recovery of myocardial energetic balance is not necessary to re-
establish an adequate cardiac structure and function, suggesting
that the beneficial CV effects of a short and mild CR are
independent from metabolic remodeling, at least in an early
stage of obesity. Therefore, the cellular hypertrophic response
at the early stage of obese cardiomyopathy in young fa/fa rats
is probably secondary to increased wall stress forced by cavity
dilatation and increased filling pressures, and not to metabolic
remodeling.
It is important to consider that, in contrast to lean rats CR
avoided the weight gain in fa/fa rats. This maintenance of BW
during the 2 weeks of CR was associated with only a moderate
loss of BW in fa/fa CR relative to fa/fa AL rats at the end of
the study. However, this absence of weight gain in fa/fa CR rats
probably favored that these rats did not develop hypertension and
the subsequent cardiac alterations associated with a compensated
hypertrophy. Therefore, mild CR provides clinically valuable
cardioprotective effects in terms of structure and function,
and can prevent obese cardiomyopathy without the need for
extreme weight loss. In contrast to our approach, the majority
of published studies using experimental models where cardiac
benefits are linked to CR were carried out under more severe CR
regimens (30–65%), during long-term (several months), and/or
on aging-animals (Dolinsky et al., 2010; Niemann et al., 2010;
Shinmura et al., 2011; Finckenberg et al., 2012; Takatsu et al.,
2013; Kobara et al., 2015; Melo et al., 2016). Along the same line,
human obese cardiomyopathy in adulthood complicated by the
presence of hypertension is associated with alterations in cardiac
structure and function (Meyer et al., 2006; Hammer et al., 2008).
In this setting, long-term CR during several months (Hammer
et al., 2008) or even years (Meyer et al., 2006) as well as after
bariatric surgery (Ikonomidis et al., 2007) has been demonstrated
to improve myocardial function especially at the diastolic level.
However, CR regimes for prolonged periods and/or with an
appreciable reduction in food intake are difficult to implement
and sustain in the obese population.
Finally, it is important to note that alterations in cardiac
function and morphology present in obese adults are also
apparent in the younger obese population. Thus, obesity,
hypertension and concentric cardiac hypertrophy are
independent predictors of diastolic dysfunction in obese
children and adolescents (Dhuper et al., 2011). In this sense, the
present study together with recent results from our group that
demonstrate a restoration in impaired endothelial dysfunction in
obese Zucker rats (García-Prieto et al., 2015), offer some insight
into the effects that mild and short-term CR have in terms of CV
prevention in obesity at an early stage. Our results support data
from other studies that affirm that the positive benefits of CR are
greater when sooner CR starts (Han and Ren, 2010; Melo et al.,
2016) and, as demonstrated in the present study, CV benefits
can occur without changes in the cardiac metabolic profile. One
limitation of this study is not having cardiac pre-CR values in
fa/fa animals in order to demonstrate whether the mild and short
CR applied here was able to prevent or revert cardiac damage.
Nonetheless, it is very likely that fa/fa AL rats did not have an
established obesity-induced cardiomyopathy just before starting
CR at 12 weeks of age, supporting the assumption that the mild
and short-term CR applied here would be able to prevent the
development of cardiac damage in these animal.
In summary, our results indicate that mild and short-term
CR protects hearts from obesity-related cardiomyopathy even
when the cardiometabolic profile remains altered. Therefore,
early dietary intervention with amoderate CR of easy compliance
when obese cardiomyopathy is first detected might reverse key
cardiac alterations linked to obesity.
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